Drug Safety Information for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (Dexamethasone; neomycin sulfate; polymyxin b sulfate)

Safety-related Labeling Changes for MAXITROL (DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) Rx Drug: FDA Link

Adverse Drug Reactions for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE* (Dexamethasone; neomycin sulfate; polymyxin b sulfate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Visual acuity reduced23
2Endophthalmitis19
3Post procedural complication15
4Dyspnoea13
5Blindness13
6Respiratory failure12
7Oedema peripheral10
8Eye irritation10
9Eye pain9
10Malaise9
11Ulcerative keratitis9
12Toxic anterior segment syndrome9
13Encephalitis8
14Pain8
15Septic arthritis staphylococcal8
16Diarrhoea8
17Intraocular pressure increased8
18Status epilepticus8
19Brain oedema8
20Convulsion8

* This side effect also appears in "Top 10 Side Effects of NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication125
2Postoperative care35
3Conjunctivitis28
4Prophylaxis26
5Dry eye14
6Inflammation13
7Eye infection10
8Cataract operation7
9Intraocular lens implant7
10Antiinflammatory therapy6

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Total Reports Filed with FDA: 1030


Number of FDA Adverse Event Reports by Patient Age for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Total Reports Filed with FDA: 1030*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Dexamethasone; neomycin sulfate; polymyxin b sulfate (Dexasporin, Dexacidin, Methedex, Npd, Neo-poly-dex, Maxitrol)

Charts are based on 1030 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE's side effects.